Alzheimer Mechanisms and Therapeutic Strategies
Tuesday, Oct 16, 2012, 10:00 AM -11:10 AM
Gladstone Inst. of Neurolog. Dis., Univ. of California - San Francisco, SAN FRANCISCO, CA
Alzheimer’s disease poses enormous medical and socioeconomic problems. It also raises fascinating neuroscientific questions about the mechanisms by which diverse molecules cause synaptic, network, and cognitive dysfunction. Several mechanisms will be discussed, including abnormal shifts in the activation of specific glutamate receptors and impairments of interneurons that regulate oscillatory network activity. The lecture highlights how novel mechanistic insights may be translated into better treatments to prevent, halt and reverse this devastating condition.
Research Grant; Research grant from Bristol-Myers Squibb. Consultant/Advisory Board; AgeneBio (SAB member), iPierian (SAB member), Link Medicine (Consultant), MPM Capital (Consultant), Neuropore Therapies (SAB member), Pfizer (Consultant), ProBiodrug (SAB member), Sanofi Aventis (Consultant), Summer Street Research Partners (Consultant). Other; Esai (Lecturer), Takeda (Lecturer).
[Authors]. [Abstract Title]. Program No. XXX.XX. 2012 Neuroscience Meeting Planner. New Orleans, LA: Society for Neuroscience, 2012. Online.
2012 Copyright by the Society for Neuroscience all rights reserved. Permission to republish any abstract or part of any abstract in any form must be obtained in writing by SfN office prior to publication.
Please remember to create a new itinerary account for this year before adding items to your itinerary.
When adding items to your Itinerary, please click "Add Checked Selections to My Itinerary" on
page of your search results.
About the Meeting
Fellowships, Awards, and Prizes
Frequently Asked Questions
Download Abstracts and
Daily Books (updated 10/13/2012) to Your E-Reader Devices
OASIS Technical Support.
Monday - Friday, 9 am - 5 pm CT
The Online Abstract Submission and Invitation System
© 1996 - 2013 Coe-Truman Technologies, Inc. All rights reserved.